Join
Live feed
·
NEWSReleasevia Quantisnow
Dermata Therapeutics Inc. logo

Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System

ByQuantisnow·Wall Street's wire, on your screen.
DRMA· Dermata Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DRMA (Dermata Therapeutics Inc.) and more on Quantisnow.